VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
166 hedge funds and large institutions have $444M invested in Verve Therapeutics in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
-7
Holders Change %
-4.05%
% of All Funds
2.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
63
Reduced
54
Closed
26
Calls
$734K
Puts
$926K
Net Calls
-$192K
Net Calls Change
+$579K
Top Buyers
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$2.35M |
| 2 |
2
Millennium Management
New York
|
$22.1M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$18.2M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$729K |
| 5 |
CSS
5
Cubist Systematic Strategies
Stamford,
Connecticut
|
$663K |
